USAQ — QHSLab, Inc.

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 856984 ·
Last close
$0.37
Market Cap
$5.52M
52W High
$1.14
52W Low
$0.18
ADV30
2,003
Next earnings
—
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 677,172 468,463 -50,404 -53,145 1,753,021 190,464 247,114
Jun 2026 847,490 589,784 45,245 38,030 1,934,874 317,392 375,822
Mar 2026 728,685 470,803 -94,380 -103,906 1,889,027 362,088 368,005
Dec 2025 703,810 488,259 35,506 556,573 2,171,006 636,157 546,078

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-107,427
Investing CF
—
Financing CF
$256,461
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-3,969,427
Inventory
$8,814
Receivables
$342,886
ST Investments
—
EBIT TTM
$646,208
Pretax Income TTM
$524,108
Interest Exp TTM
$122,100
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,017,051
EBITDA
$154,734
Free Cash Flow
$-568,572
Enterprise Value
$4,583,472
Total Cash
$317,392
Total Debt
$90,000
Shares Out
15,032,788
Trailing EPS
$0.03
Book Value
$0.11
ROE
114.6%
ROA
2.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,691,741 131,244 457,417 2,171,006 546,078 1,624,928 178,118
Dec 2024 2,131,926 205,738 -259,239 1,799,552 2,407,308 -607,756 142,437
Dec 2023 1,408,995 -240,158 -468,362 1,681,432 2,057,049 -375,617 -159,627
Dec 2022 1,243,186 -560,539 -996,001 1,957,453 1,881,208 76,245 -350,994
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$3,017,051
NetIncome TTM
$524,108
OpCashFlow TTM
—
Assets (Latest)
$1,934,874
Forward EPS
$0.05

Peers — same industry

TickerNameMarket CapLastDaily %
IVF INVO Fertility, Inc. $5.47M $2.18 —
WOK WORK Medical Technology Group LTD $5.26M $1.19 —
NDRA ENDRA Life Sciences Inc. $5.88M $3.92 —
INBS INTELLIGENT BIO SOLUTIONS INC. $5.17M $1.56 —
CLGN CollPlant Biotechnologies Ltd $6.30M $3.33 —

News headlines (Yahoo Finance, 1h cache)

QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
2026-08-03 12:30 · Yahoo
QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment
2026-04-21 13:15 · Yahoo
QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement
2026-03-31 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.